← brief for 2026-10-20 · Slowing decline

SGLT2 Inhibitors Beyond Glycemic Control: Emerging Therapeutic Applications, Clinical Evidence, Safety and Future Perspectives

Key takeaways

This is a review of a drug called SGLT2 inhibitors. It talks about how the drug helps the heart and kidneys. This item is a preprint, so it has not passed peer review yet. There are no new results in this specific file.

Who did this work

Mayur Borade*, Ganesh Anarthe, Tejas Anarthe, Afreen Shaikh

Source

Article · OpenAlex, CKD works · 2026-10-19
https://doi.org/10.5281/zenodo.23475105